𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Coumermycin a1—biopharmaceutical studies II

✍ Scribed by Harold L. Newmark; Julius Berger; J. Thurø Carstensen

Publisher
John Wiley and Sons
Year
1970
Tongue
English
Weight
295 KB
Volume
59
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis of Coumermycin A1.
Synthesis of Coumermycin A1.
✍ Steven H. Olson; Llnon H. Slossberg 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 72 KB
Synthesis of coumermycin A1
Synthesis of coumermycin A1
✍ Steven H Olson; Llnon H Slossberg 📂 Article 📅 2003 🏛 Elsevier Science 🌐 French ⚖ 171 KB

A concise synthesis of the antibiotic coumermycin A 1 , a natural product isolated from streptomyces, was achieved. In a key step, a selectively protected noviose sugar was prepared from novobiocin through a transglycosylation reaction with acetone.

Biopharmaceutical studies on aminoethane
Biopharmaceutical studies on aminoethanesulfonylphenetidine and related compounds II
✍ Shun-Ichi Naito; Kazuo Fukui 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 864 KB

The binding ratio of taurinophenetidine or nicotinoyltaurinophenetidine with serum protein in rabbits varies according to experimental conditions in dialysis, but the averaged binding ratios of taurinophenetidine and its nicotinate were roughly 40- 50z at high doses. Taurinophenetidine and its nicot

Pharmacokinetic Profile of Coumermycin A
Pharmacokinetic Profile of Coumermycin A1
✍ Stanley A. Kaplan 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB

The pharmacokinetic profile of coumermycin A1 has been determined in man following intravenous and oral administration. The antibiotic is eliminated slowly from the bloodstream and appears to be highly biotransformed. The plasma level versus time curve after intravenous injection is consistent with